Integrated Pain Associates (“IPA”) (https://ipaclinic.com/), a Triton Pacific Healthcare Partners (“Triton Pacific”) portfolio company, is pleased to announce a partnership with Lubbock Spine Institute (“LSI”), a leading provider of interventional spine and pain management services across West Texas with 21 physicians and advanced practice providers.
Headquartered in Killeen, TX and with locations across the state, IPA has significantly expanded its geographic reach since its partnership with Triton Pacific in 2023 and continues to fulfill its mission of addressing unmet need in underserved areas. In partnership with LSI, the platform expands its footprint to include Lubbock, Midland, and Amarillo, TX. Patients will benefit from increased access to a broad array of minimally invasive procedures and therapies that are provided outside of hospitals and target the root causes of pain.
“The pain management space has undergone a meaningful evolution, shifting away from the archaic dichotomy between invasive surgeries and medication management to center on minimally invasive procedures that produce better outcomes,” commented Dr. Scott Irvine, President of IPA. “IPA and LSI share a commitment to advancing this superior clinical model and providing best-in-class care for our patients.”
While clinical innovation has created substantial opportunity, operational complexity and limited access to training have prevented many pain management practices from participating in this evolution. Elodie Day, CEO of IPA, noted: “We view ourselves not only as a forerunner but also as a driver of the paradigm shift. The partnership between IPA and LSI provides even greater impetus behind our efforts. LSI is strongly aligned with our vision and brings a highly skilled team of providers that are ideally equipped to help promote our shared goals.”
Dr. Bolkar Sahinler of LSI commented: “We are immensely excited to partner with IPA. This is an opportunity for us to participate in building a truly differentiated platform where clinical excellence and strategic thinking converge. With the combined capabilities of IPA and LSI, we anticipate meaningful benefits for both patients and providers.”
Terms of the transaction were not disclosed. Florac and Star Mountain participated as significant investors in the platform. DLA Piper, led by Sal Favuzza and Joshua Kaye, advised IPA and Triton Pacific. Manatt, Phelps & Phillips, led by Scott Schwartz and Paul Carr-Rollitt, advised LSI.
About IPA
IPA is a leading minimally invasive spine and pain management platform that expands access to care to underserved markets outside of major metropolitan areas. IPA is highly differentiated with a talented team of physicians trained in a wide range of interventional procedures that reduce reliance on opioids and produce better outcomes for patients. Leveraging unique in-house clinical expertise in conjunction with sophisticated management services, IPA drives value by keeping cases out of high-cost hospital environments and reducing overall costs of care.
About Triton Pacific
Triton Pacific Healthcare Partners (https://tritonpacifichealthcare.com/), founded in 2001, is a private equity group offering unique investment opportunities to institutional and high net worth investors. Its healthcare division, Triton Pacific Healthcare Partners, has a dedicated healthcare investment team with a demonstrated track record of successfully sourcing, acquiring, and managing healthcare investments. Triton Pacific has completed over 30 transactions, including eleven healthcare services platforms, as well as multiple add-ons across the portfolio.